Paringa Silo Art Trail showcases Riverland identities in ‘outstanding’ large-scale artwork


Four prominent, colourful faces rise above the Murray River in the small regional town of Paringa, each depicting an iconic character or familiar river scene inside.

The large-scale artwork, which is the latest stop on the silo art trail, has been dubbed “the silo art gateway to South Australia” and is already drawing in plenty of visitors to the Riverland town.

Paringa Silo Art Trail spokesman Les Webb said “99.99 per cent” of tourists found the artwork “just so special”.

“And so that’s very pleasing,” he said.

The project, which was spearheaded by Mr Webb, was in the planning phase for a number of years before enough funds were raised for artist Jack Fran to take to the canvas late last year.

“Jack has really captured the colours fantastically.”

Renmark-born riverboat captain Pearl Wallace is the first prominent face people see as they pass across the historic Paringa Bridge, heading out of Renmark.

She was Australia’s first female riverboat captain who, from the late 1940s, could take the wheel of any commercial vessel and became the inspiration for Nancy Cato’s novel, All Rivers Run.

“Inside her face, we have a picture of the PS Industry passing Heading’s Cliffs,” Mr Webb said.

Gazing across from Wallace is the face of Charles Chaffey, the manager of the Renmark irrigation settlement in the late 1800s.

He was summonsed to Australia to look after the riverside district by his older brothers William and George, who created the first irrigation districts in Australia.

David Jones, better known as Possum because of his habit of sleeping in trees and raiding beehives for honey, also features on the distinct silo artwork within Chaffey’s face, looking out across the riverside landscape.

It was in this landscape that the local identity spent many of his days living off the bush and roaming between Renmark and Wentworth, after losing his shearer’s ticket during the Depression.

Documented as a shy man, Possum liked to spend time on his own, he was known to have mended fences, chopped wood, cleared weeds and crutched sheep at the many stations he passed through.

On the reverse side of the silos, the theme of nature continues, as local Aboriginal identity George Disher’s head provides a backdrop for the creator of the Murray River, Pondi the Murray cod.

Disher, who lived in the Riverland area around the 1920s, was described by the local newspaper’s editor Arch Grosvenor as a “local institution”.

A favourite with the community and passers-by, people would pay him two shillings to write and date a sentence backwards, which could be read when held in front of a mirror.

His face featured alongside Sister Elaine Balfour-Ogilvy in the artwork, a Renmark-born World War II nurse who was executed by Japanese soldiers at Banka, an island east of Sumatra.

Her memory is now immortalised in the silo art, alongside the Renmark Children’s Library and a local road, which are both named after her.

“There were many candidates that could’ve been used but we tried to have an even balance of men and women and characters of significance.”

Future plans for the site include lighting installations around the silos, viewing shelters and signs with QR codes to help promote the region.

We hope you enjoyed seeing this news update involving “What’s On in the Mildura to Swan Hill Region titled “Paringa Silo Art Trail showcases Riverland identities in ‘outstanding’ large-scale artwork”. This news article was presented by My Local Pages as part of our current events and news aggregator services.

#Paringa #Silo #Art #Trail #showcases #Riverland #identities #outstanding #largescale #artwork



Source link

COVID-19: Vaccines giving 67% protection after three weeks, large-scale research shows | UK News


One dose of a COVID-19 vaccine gives 67% protection after three weeks, a leading epidemiologist has said.

Professor Tim Spector of King’s College London, who runs the ZOE COVID-19 surveillance app, said data collected from 50,000 users vaccinated with either the Pfizer or Oxford/AstraZeneca jab showed one dose gave 46% protection after two weeks, rising to 67% after three to six weeks.

The app uses information submitted by more than four million users across the world to predict and track coronavirus infections across the UK and other countries.

“We have now got about a third of a million people who have logged their first dose of the vaccine with us on the ZOE app,” Prof Spector told Sky’s Sophy Ridge on Sunday

“We are showing very low levels of side effects and we’ve showed that after three weeks we’re getting a 67% protection against the virus, so three times less risk than you’d be getting otherwise compared to an unprotected control.

“That is a better rate than people had thought just on a single jab so I think that, combined with the data we’re seeing, has given me a lot of reason to be optimistic that we are going to be in a much better place in two to four weeks’ time and can start to reduce some of these restrictions.”

Asked about the sample size, he said: “We have analysed around the first 50,000 people so it is a large sample and these are healthcare workers who are at high risk, so they are the ones you would see changes in most and we’re seeing a consistent fall, with no protection at all in the first two weeks… but after two weeks it drops to around 46% and after three to six weeks it is 67%, which is really great.

“If that was around the country, we would have really knocked this virus on the head.”

Image:
Professor Tim Spector has been examining collected data on vaccine efficacy

The figure was calculated using “large-scale, real-time data” from two control groups of healthcare workers – one group vaccinated and one not. The level of protection was measured against a PCR proven infection compared to a control group of same age and gender also reporting on the app.

Different studies suggest different effectiveness for one jab of the two vaccines currently on offer – the Pfizer/BioNTech and Oxford/AstraZeneca jabs.

According to Pfizer data from December 2020, the Pfizer-BioNTech vaccine is roughly 52% effective 12 days on from the first dose. This rises to 95% with a second jab.

And data from Israel’s vaccination programme suggests one jab could offer just 33% protection.

This was contradicted by a UK Joint Committee on Vaccination and Immunisation study which found one Pfizer jab to be 89% effective, rising to 92% with a second jab.

Subscribe to the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Meanwhile, according to a scientific paper in the Lancet from January, the Oxford/AstraZeneca jab offers protection of 64.1% 21 days after one dose and 70.4% after two doses.

On Wednesday, early results of the vast UK study on the impact of the Pfizer-BioNTech and Oxford-AstraZeneca vaccine rollout suggests that the level of protection from one jab was about 60% to 65%.

The results applied to vaccine recipients of all ages, and protection began after two weeks.

Please use Chrome browser for a more accessible video player

‘Come forward and get jabbed,’ says national medical director for England

A draft has been sent to the government but on Wednesday Sir Patrick Vallance, the government’s chief scientific adviser, said he was not publishing its results yet because he wanted more data.

The figures, first reported in The Sun and confirmed by a Whitehall source, showed that one dose reduced the symptomatic infection risk by 65% in younger adults and 64% in over-80s.

Protection for those given two shots rose to between 79% and 84%, depending on age.

We hope you enjoyed checking out this article involving current European news called “COVID-19: Vaccines giving 67% protection after three weeks, large-scale research shows | UK News”. This news article was shared by My Local Pages as part of our news aggregator services.

#COVID19 #Vaccines #giving #protection #weeks #largescale #research #shows #News



Source link

China prepares large-scale rollout of COVID-19 vaccines


Provincial governments across China are placing orders for experimental, domestically made coronavirus vaccines, though health officials have yet to say how well they work or how they may reach the country’s 1.4 billion people.

Developers are speeding up final testing, the Chinese foreign minister said on Thursday during a UN meeting, as Britain issued approval for emergency use of Pfizer’s vaccine candidate and providers scrambled to set up distribution.

China’s fledgling pharmaceutical industry has at least five vaccines from four producers being tested in more than a dozen countries including Russia, Egypt and Mexico.

Health experts say even if they are successful, the certification process for the United States, Europe, Japan and other developed countries might be too complex for them to be used there.

However, China said it will ensure the products are affordable for developing countries.

Sinovac is running clinical trials in Brazil, Turkey and Indonesia.(AP: Emrah Gurel)

One developer, China National Pharmaceutical Group, known as Sinopharm, said in November it applied for final market approval for use of its vaccine in China.

Others have been approved for emergency use on health workers and other people deemed at high risk of infection.

“We must be prepared for large-scale production,” said Vice-Premier Sun Chunlan, who has overseen much of the country’s response, during a visit Wednesday to developers, according to the official Xinhua News Agency.

Ms Sun visited one of Sinopharm’s Beijing subsidiary companies; another producer, Sinovac, and a research lab under the National Medical Products Administration, a regulatory agency that approves medical products for public use.

The Government has yet to say how many people it plans to vaccinate. Ms Sun said plans call for vaccinating border personnel and other high-risk populations this month.

Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.
Yilu Wu was given the first of two shots of a vaccine candidate produced by pharmaceutical company Sinovac.

Vaccines can be stored at higher temperatures than Pfizer’s, say companies

The companies are using more traditional techniques than Western developers.

They say unlike Pfizer’s vaccine, which must be kept frozen at temperatures as low as minus 70 degrees Celsius, theirs can be stored at 2 to 8 degrees.

The Chinese producers have yet to say how they might be distributed.

More than 1 million people in China have received experimental vaccines under emergency use approval.

Health experts question why China is using them on such a vast scale now that the outbreak is largely under control within its borders.

Health officials previously said China will be able to manufacture 610 million doses by the end of this year and ramp up to 1 billion doses next year.



Source link

While Europe and USA close everything down, Russia holds large-scale music concerts


The chairman of the Committee for Culture of St. Petersburg, Konstantin Sukhenko, was reprimanded for improper coordination of the work of cultural organizations to ensure compliance with sanitary measures to curb the spread of the new coronavirus infection.

The official was reprimanded after the head of Rospotrebnadzor (Russian Federal Agency for Health and Consumer Rights), Anna Popova, criticized the authorities of St. Petersburg for holding a music concert of rapper Basta. The rapper played two concerts at the “Ice Palace” sports complex of St. Petersburg, which had the attended of over 12,000 viewers in total. 

The videos from the concert shows people standing at the concert without any social distancing, many were not wearing face masks. It was also reported that many viewers stood up from the seats and moved freely in the hall, having thus congregating into a crowd. 

Deputy director general of the Ice Palace for legal issues, Georgy Nikolov, stated in response to the allegations that the video did not display everything clearly, and the venue was not more than 50% full. 

Representatives of the press service of the artist also said that they followed the instructions from the authorities of St. Petersburg and Rospotrebnadzor, whereas a representative of the Committee on Culture of St. Petersburg attended the concert on November 27 at the Ice Palace and did not report a single violation, RIA Novosti reports.


“All the requirements listed in the decree by the Governor of St. Petersburg were met, all notification letters were signed at city structures. The venue was 50 percent full at the concert. Many report about the permissible level of 25 percent, but this rule takes effect only from December 1. At our concert there were no tickets without seats, there were no standing area tickets either, all the viewers were sitting at their seats,” Basta said in his video address that he posted on Instagram.


He also said that face masks were distributed among the viewers, and there were hand sanitisers provided in the foyer. According to the musician, his concert became “a lump in the throat” for other organizers, who did not find either strength or professionalism to prepare for music concerts in accordance with the new rules during the coronavirus pandemic. 

On November 30, Anna Popova, the head of Rospotrebnadzor, ordered to check how safety measures were observed at the concerts. She said at a meeting of the epidemic coordination council on December 1, that “it is unacceptable to hold such events” against the background of the  current coronavirus crisis. Russian Prime Minister Mikhail Mishustin supported her point of view. As a result, the Ice Palace in St. Petersburg was closed, and the materials on the revealed violations were sent to court.

As many as 589 coronavirus patients have died in the last 24 hours in Russia. This number set a new record in the history of coronavirus records in the Russian Federation since the beginning of the pandemic. Of these, 82 people died in St. Petersburg, 75 – in Moscow, 32 – in the Moscow region.

In total, 41,053 patients with coronavirus have died in Russia since the beginning of the pandemic; the number of positive cases current counts 2,347,401 people.

The previous daily mortality record was set a day earlier, December 1, when 569 deaths were reported.



Source link